The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Quantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal Carcinoma
Open accessAbstract
BACKGROUND: We investigated the clinical significance of plasma concentrations of Epstein-Barr virus (EBV) DNA in patients with advanced nasopharyngeal carcinoma. METHODS: Ninety-nine patients with biopsy-proven stage III or IV nasopharyngeal carcinoma and no evidence of metastasis (M0) received 10 weekly chemotherapy treatments followed by radiotherapy. Plasma samples from the patients were subjected to a real-time quantitative polymerase-chain-reaction assay. EBV genotypes of paired samples from plasma and primary tumor were compared. RESULTS: Plasma EBV DNA was detectable before treatment in 94 of the 99 patients, but not in 40 healthy controls or 20 cured patients. The median concentrations of plasma EBV DNA were 681 copies per milliliter among 25 patients with stage III disease, 1703 copies per milliliter among 74 patients with stage IV disease, and 291,940 copies per milliliter among 19 control patients with distant metastasis (P<0.001). Patients with relapse had a significantly higher plasma EBV DNA concentration before treatment than those who did not have a relapse (median, 3035 vs. 1202 copies per milliliter; P=0.02). The consistent genotyping of EBV DNA between paired samples of plasma and primary tumor suggested that the circulating cell-free EBV DNA may originate from the primary tumor. Unlike the rebound of plasma EBV DNA concentrations in the patients who had a relapse, the plasma EBV DNA concentration was persistently low or undetectable in patients with a complete clinical remission. Overall survival (P<0.001) and relapse-free survival (P=0.02) were significantly lower among patients with pretreatment plasma EBV DNA concentrations of at least 1500 copies per milliliter than among those with concentrations of less than 1500 copies per milliliter. Patients with persistently detectable plasma EBV DNA had significantly worse overall survival (P<0.001) and relapse-free survival (P<0.001) than patients with undetectable EBV DNA one week after the completion of radiotherapy. CONCLUSIONS: Quantification of plasma EBV DNA is useful for monitoring patients with nasopharyngeal carcinoma and predicting the outcome of treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Al-Sarraf, M., LeBlanc, M., Giri, P. G., Fu, K. K., Cooper, J., Vuong, T., Forastiere, A. A., Adams, G., Sakr, W. A., Schuller, D. E., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1310 · Cited by 2,222
The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation
Raab-Traub, N., & Flynn, K. (1986) · Cell · doi:10.1016/0092-8674(86)90803-2 · Cited by 912
(15031584), Y. M. D. L., Chan, L. Y. S., Lo, K. W., Leung, S. F., Zhang, J., Chan, A. T. �., Lee, J. C., Hjelm, N. M., Johnson, P. J., & Huang, D. P. (1999) · PubMed · Cited by 777
Lin, J.-C., Jan, J.-S., Hsu, C.-Y., Liang, W.-M., Jiang, R.-S., & Wang, W.-Y. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.158 · Cited by 762
Self-citationPathmanathan, R., Prasad, U., Sadler, R., Flynn, K., & Raab-Traub, N. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509143331103 · Cited by 620
Serologic Markers of Epstein–Barr Virus Infection and Nasopharyngeal Carcinoma in Taiwanese Men
Chien, Y.-C., Chen, J.-Y., Liu, M.-Y., Yang, H.-I., Hsu, M.-M., Chen, C.-J., & Yang, C.-S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011610 · Cited by 487
Chan, A. T. �., Lo, Y. M. D., Zee, B., Chan, L. Y. S., Ma, B. B. Y., Leung, S.-F., Mo, F., Lai, M., Ho, S., Huang, D. P., et al. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.21.1614 · Cited by 452
Lo, Y. M. D., Chan, L. Y. S., Chan, A. T. �., Leung, S. F., Lo, K. W., Zhang, J., Lee, J. C., Hjelm, N. M., Johnson, P. J., & Huang, D. P. (1999) · PubMed · Cited by 390
Lo, Y. M. D., Chan, A. T. �., Chan, L. Y. S., Leung, S. F., Lam, C., Huang, D. P., & Johnson, P. J. (2000) · PubMed · Cited by 341
Chan, K. C. A., Zhang, J., Chan, A. T. �., Lei, K. I. K., Leung, S. F., Chan, L. Y. S., Chow, K. C., & Lo, Y. M. D. (2003) · PubMed · Cited by 251
Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma.
Mutirangura, A., Pornthanakasem, W., Theamboonlers, A., Sriuranpong, V., Lertsanguansinchi, P., Yenrudi, S., Voravud, N., Supiyaphun, P., & Poovorawan, Y. (1998) · PubMed · Cited by 197
Epstein-Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer.
Shotelersuk, K., Khorprasert, C., Sakdikul, S., Pornthanakasem, W., Voravud, N., & Mutirangura, A. (2000) · PubMed · Cited by 141
Chang, Y., Tyan, Y. S., Liu, S. T., Tsai, M.-S., & Pao, C. C. (1990) · Journal of Clinical Microbiology · doi:10.1128/jcm.28.11.2398-2402.1990 · Cited by 104
Lo, Y. M. D., Leung, S. F., Chan, L. Y. S., Lo, K. W., Zhang, J., Chan, A. T. �., LEE, J. C. K., Hjelm, N. M., Johnson, P. J., & Huang, D. P. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06597.x · Cited by 93
Henderson, Y. C., Breau, R. L., Liu, T.-J., & Clayman, G. L. (2000) · Head & Neck · doi:10.1002/1097-0347(200007)22:4<336::aid-hed4>3.0.co;2-t · Cited by 52
Detection of cell free Epstein–Barr virus DNA in sera from patients with nasopharyngeal carcinoma
Hsiao, J., Jin, Y.-T., & Tsai, S. (2002) · Cancer · doi:10.1002/cncr.10251 · Cited by 50
Cited by
Cell-free nucleic acids as biomarkers in cancer patients
Schwarzenbach, H., Hoon, D. S. B., & Pantel, K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3066 · Cited by 2,891
Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing
Espy, M. J., Uhl, J. R., Sloan, L. M., Buckwalter, S. P., Jones, M. F., Vetter, E. A., Yao, J. D. C., Wengenack, N. L., Rosenblatt, J. E., Cockerill, F. R., et al. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.165-256.2006 · Cited by 1,318
The Enigmatic Epidemiology of Nasopharyngeal Carcinoma
Chang, E. T., & Adami, H.-O. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0353 · Cited by 1,297
Wei, W. I., & Sham, J. S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66698-6 · Cited by 1,208
Sun, Y., Li, W.-F., Chen, N.-Y., Zhang, N., Hu, G.-Q., Xie, F.-Y., Sun, Y., Chen, X.-Z., Li, J.-G., Zhu, X.-D., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30410-7 · Cited by 950
Metadata
- Authors
- Lin, J.-C., Wang, W.-Y., Chen, K. Y., Wei, Y.-H., Liang, W.-M., Jan, J.-S., & Jiang, R.-S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-06-10
- Volume
- 350
- Issue
- 24
- Pages
- 2461-2470
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1968017437
- Cited by
- 909
- References
- 17
- FWCI
- 10.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.